1832 Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218M Sell
451,800
-398,900
-47% -$106M 0.11% 96
2026
Q1
$93.2M Sell
850,700
-496,300
-37% -$70.7M 0.09% 167
2025
Q4
$224M Buy
1,347,000
+386,500
+40% +$64.7M 0.17% 86
2025
Q3
$188M Sell
960,500
-583,000
-38% -$95.9M 0.15% 84
2025
Q2
$140M Buy
1,543,500
+929,600
+151% +$73.4M 0.11% 107
2025
Q1
$36.6M Sell
613,900
-1,527,300
-71% -$141M 0.03% 233
2024
Q4
$284M Buy
+2,141,200
New +$201M 0.24% 50

Other funds holding ALAB

1832 Asset Management's ALAB Position: Q2 2026 in Review

1832 Asset Management reduced its Astera Labs (ALAB) stake by 47% in Q2 2026, selling an estimated $106M and leaving 451,800 shares worth $218M. The position accounts for 0.11% of the portfolio, ranked #96.

1832 Asset Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $284M in Q4 2024. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • 1832 Asset Management held 451,800 shares of Astera Labs worth $218M as of Q2 2026.
  • 1832 Asset Management sold 398,900 Astera Labs shares in Q2 2026, an estimated $106M.
  • Astera Labs made up 0.11% of 1832 Asset Management's portfolio in Q2 2026, its #96 holding.
  • 1832 Asset Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 1832 Asset Management's Astera Labs position peaked at $284M in Q4 2024.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.